Published March 9, 2026 | Version v1

Polysaccharide-Based Oral Colon-Targeted Drug Delivery Systems for Colorectal Cancer Therapy: Current Advances and Future Perspectives

Description

Colorectal cancer (CRC) is a major cause of cancer morbidity and mortality worldwide. Chemotherapy is usually administered by injection to stop the development and spread of tumour. Oral administration of medications in the form of a colon-specific delivery system is expected to reduce systemic side effects, reduce the dosage of the drug, and increase drug bioavailability at the target site when compared to injection. Polysaccharides can be utilized as a matrix or coat material for oral delivery to shield drugs from chemical and enzymatic deterioration. Natural polysaccharides are widely used in the development of solid dosage forms that carry medications to the colon. It makes sense to create a polysaccharide-based delivery system for the human colon since it is home to a diverse spectrum of bacteria that secrete a number of enzymes, including β-d-glucosidase, β-d-galactosidase, amylase, pectinase, xylanase, β-d-xylosidase, dextranase, etc. This review article provides an overview of the use of chitosan, pectin, guar gum, inulin, lactulose, amylose, and alginate as drug carriers for the treatment of colorectal cancer.

Files

46-Dr Manoj K.pdf

Files (4.4 MB)

Name Size
md5:33a2179d33542c15f069c4d05dd5971b
4.4 MB Preview Download